EUVIMEDEUVIMED entdecken
Kohortenstudie

Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan

Hsin-Yin Hsu iD, Yih-Jong Chern iD, Min-Shu Hsu, Tzu-Lin Yeh iD, Ming-Chieh Tsai iD, Jing-Rong Jhuang iD, Cheng-Tzu Hsieh iD, Chun-Ju Chiang iD, Wen-Chung Lee iD, Lee-Ching Hwang iD, Kuo-Liong Chien iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae257 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Hsin-Yin Hsu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Mackay Memorial Hospital, Taipei City 104217, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Science and Technology Council of Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The association between colorectal cancer (CRC) and new-onset diabetes mellitus remains unclear.

Objective

To examine the association between CRC and the risk of subsequent diabetes mellitus and to further investigate the impact of chemotherapy on diabetes mellitus risk in CRC.

Methods

In this nationwide cohort study using the Taiwan Cancer Registry database (2007-2018) linked with health databases, 86 268 patients with CRC and an equal propensity score-matched cohort from the general population were enrolled. Among them, 37 277 CRC patients from the Taiwan Cancer Registry (2007-2016) were analyzed for diabetes mellitus risk associated with chemotherapy. Chemotherapy exposure within 3 years of diagnosis was categorized as no chemotherapy, < 90 days, 90 to 180 days, and > 180 days. Differences in diabetes mellitus risk were assessed across these categories.

Results

Each group involved 86 268 participants after propensity score matching. The patients with CRC had a 14% higher risk of developing diabetes mellitus than the matched general population (hazard ratio [HR]: 1.14; 95% CI, 1.09-1.20). The highest risk was observed within the first year after diagnosis, followed by a sustained elevated risk. Long-term chemotherapy (> 180 days within 3 years) was associated with a 60% to 70% increased risk of subsequent diabetes mellitus (HR: 1.64; 95% CI, 1.07-2.49).

Conclusion

Patients with CRC are associated with an elevated risk of diabetes mellitus, and long-term chemotherapy, particularly involving capecitabine, increases diabetes mellitus risk. Thus, monitoring blood glucose levels is crucial for patients with CRC, especially during extended chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDiabetes MellitusHumansTaiwanFemaleMaleMiddle AgedAgedRisk FactorsRegistriesCohort StudiesAdultPropensity ScoreFollow-Up StudiesIncidence

Stichwörter der Autor:innen

cancer chemotherapycapecitabinecolorectal cancerdiabetes mellitusintegrated medicine

Autor:innen und Institutionen

  • Department of Family Medicine, Mackay Memorial Hospital, Taipei City 104217, Taiwan.
  • Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City 10055, Taiwan.
  • Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
  • Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan City 333423, Taiwan.
  • Department of Medical Research, Mackay Memorial Hospital, New Taipei City 251020, Taiwan.
  • Department of Family Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu City 300044, Taiwan.

ORCID-Profile: Hsin-Yin Hsu, Yih-Jong Chern, Tzu-Lin Yeh, Ming-Chieh Tsai, Jing-Rong Jhuang, Cheng-Tzu Hsieh, Chun-Ju Chiang, Wen-Chung Lee, Lee-Ching Hwang, Kuo-Liong Chien

Förderung

  • National Science and Technology Council of Taiwan

Zitieren

APA

Hsu, H. Y., Chern, Y. J., Hsu, M. S., Yeh, T. L., Tsai, M. C., Jhuang, J. R., Hsieh, C. T., Chiang, C. J., Lee, W. C., Hwang, L. C., & Chien, K. L. (2025). Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae257

Vancouver

Hsu HY, Chern YJ, Hsu MS, Yeh TL, Tsai MC, Jhuang JR, et al. Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae257

BibTeX
@article{Hsu2025,
  author = {Hsu, Hsin-Yin and Chern, Yih-Jong and Hsu, Min-Shu and Yeh, Tzu-Lin and Tsai, Ming-Chieh and Jhuang, Jing-Rong and Hsieh, Cheng-Tzu and Chiang, Chun-Ju and Lee, Wen-Chung and Hwang, Lee-Ching and Chien, Kuo-Liong},
  title = {Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae257}
}
Kostenlos starten →